alpha-hydroxyglutarate has been researched along with Di Guglielmo Disease in 1 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, F | 1 |
Travins, J | 1 |
DeLaBarre, B | 1 |
Penard-Lacronique, V | 1 |
Schalm, S | 1 |
Hansen, E | 1 |
Straley, K | 1 |
Kernytsky, A | 1 |
Liu, W | 1 |
Gliser, C | 1 |
Yang, H | 1 |
Gross, S | 1 |
Artin, E | 1 |
Saada, V | 1 |
Mylonas, E | 1 |
Quivoron, C | 1 |
Popovici-Muller, J | 1 |
Saunders, JO | 1 |
Salituro, FG | 1 |
Yan, S | 1 |
Murray, S | 1 |
Wei, W | 1 |
Gao, Y | 1 |
Dang, L | 1 |
Dorsch, M | 1 |
Agresta, S | 1 |
Schenkein, DP | 1 |
Biller, SA | 1 |
Su, SM | 1 |
de Botton, S | 1 |
Yen, KE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prevalence, Correlation With Other Mutant Genes and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia. The European IDH Research Alliance[NCT04369287] | 654 participants (Anticipated) | Observational | 2016-01-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for alpha-hydroxyglutarate and Di Guglielmo Disease
Article | Year |
---|---|
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.
Topics: Allosteric Site; Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell | 2013 |